Addressing viral hepatitis C reinfections in a low-threshold programme for people who inject drugs in Slovenia.

ABSTRACT:

Background

Hepatitis C virus (HCV) infection remains a public health threat. Although therapy with direct-acting antivirals made its elimination possible, major challenges remain in treating vulnerable populations, such as people who inject drugs (PWID) enrolled in low-threshold programmes (LTPs). This study analysed the outcome of HCV management focused on HCV reinfection in a specifically designed model-of-care (MoC) for PWID in Slovenia, where treatment is prescribed without limitations, though only by specialist physicians.

Methods

All HCV antibody (anti-HCV) positive users of a MoC, combining HCV management at Clinic for Infectious Diseases at the University Medical Centre in Ljubljana and LTP for PWID in 100 km distanced civil society organisation (CSO) Svit Koper, bet

SUBMITTER: Cernosa J 

PROVIDER: S-EPMC11823079 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature